Table 5.
Data of oxygen saturation, neuromuscular strength and range of motion in baseline, pretreatment and posttreatment moments.
| Pretreatment post-treatment intragroup comparison | ||||||||
|---|---|---|---|---|---|---|---|---|
| ES standardized (90% CL) intragroups | Chances | QA | ES standardized (90% CL) between groups | Chances | QA | |||
| SmO2 | Rest | NVFR | 0.28 (-0.09;0.65) | 64/43/2 | Possibly | -0.10 (0.49;-0.70) | 20/41/39 | Unclear |
| VFR | 0.41 (-0.08;0.91) | 77/21/2 | Likely | |||||
| After ten squats | NVFR | 1.23 (0.44;2.01) | 98/1/0 | Very likely | 0.21 (0.74;-0.33) | 10/39/51 | Unclear | |
| VFR | 0.96 (0.36;1.55) | 98/2/0 | Very likely | |||||
| CMJ | NVFR | 0.42 (0.3;0.54) | 100/0/0 | Very likely | -0.09 (-0.24;0.05) | 0/89/11 | Unclear | |
| VFR | 0.29 (0.2;0.38) | 95/5/0 | Very likely | |||||
| Hip joint ROM | Active | NVFR | 0.53 (0.32;0.73) | 99/1/0 | Very likely | 0.31 (-0.02;0.64) | 71/28/1 | Unclear |
| VFR | 0.91 (0.63;1.19) | 100/0/0 | Very likely | |||||
| Passive | NVFR | 0.34 (0.14;0.53) | 88/12/0 | Likely | 0.36 (0.01;0.72) | 78/22/1 | Likely | |
| VFR | 0.71 (0.45;0.97) | 100/0/0 | Very likely | |||||
| Knee joint ROM | Active | NVFR | 0.62 (0.48;0.76) | 100/0/0 | Very likely | 0.19 (-0.01;0.39) | 47/52/0 | Unclear |
| VFR | 0.48 (0.33;0.62) | 100/0/0 | Very likely | |||||
| Passive | NVFR | 0.43 (0.23;0.63) | 97/3/0 | Very likely | 0.05 (-0.18;0.28) | 14/82/4 | Unlikely | |
| VFR | 0.26 (0.1;0.42) | 74/26/0 | Possibly | |||||
ES, effect size; CL, confidence limits; QA, qualitative assessment; CMJ, countermovement jump; SmO2, muscle oxygen saturation; ROM, range of motion.